Last reviewed · How we verify

NCT06674551

Suprascapular and Axillary Versus Interscalene Blocks Regarding Phrenic Affection in Shoulder Surgeries

Not yet recruiting NA Last updated 5 November 2024
What this trial tests

NA trial testing Suprascapular nerve block and Axillary nerve block in Interscalene Nerve Block in 60 participants. Not yet recruiting.

Timeline
20 November 2024
Primary endpoint
1 October 2025
1 November 2025

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment60
Start date20 November 2024
Primary completion1 October 2025
Estimated completion1 November 2025

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Interscalene Nerve Block or Suprascapular Nerve. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is aims to compare between combined suprascapular and axillary nerve blocks versus interscalene nerve block regarding phrenic nerve affection assessed by ultrasound guided diaphragmatic excursion in shoulder arthroscopy surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06674551.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing